BiomX Inc. Amends Charter for Proposed Reverse Stock Split

What Happened
BiomX Inc. (PHGE) filed an amendment to its Current Report on Form 8-K on September 1, 2026, disclosing an amendment to its articles of incorporation related to a proposed reverse stock split and the anticipated treatment of fractional shares. The filing includes forward‑looking statements about the timing and effects of the reverse split and notes that effectiveness depends on the filing of a Certificate of Amendment and processing by the NYSE American and DTC. The company references risks described in its Annual Report on Form 10‑K for the year ended December 31, 2025 and its Quarterly Report on Form 10‑Q for the quarter ended June 30, 2026.

Key Details

• Filing date: September 1, 2026 (Current Report amendment).
• Item: 5.03 — Amendment to Articles of Incorporation/Bylaws concerning a reverse stock split and fractional‑share treatment.
• The amendment’s timing and final effects depend on filing/effectiveness of a Certificate of Amendment and processing by NYSE American and the DTC.
• The filing reiterates standard forward‑looking statement language and references the company’s prior risk disclosures; it does not update other disclosures in the Original Report.

Why It Matters
A reverse stock split, if implemented, will change the company’s share count and the per‑share price, and can affect liquidity and how fractional shares are handled (typically cash‑out or rounding). The filing signals corporate action that could affect existing shareholders’ holdings and trading activity; investors should monitor subsequent filings for the Certificate of Amendment, the split ratio, the effective date, and any instructions on fractional‑share treatment. Review BiomX’s 10‑K/10‑Q risk disclosures for additional context on timing and execution risks.